A Pilot Case Control Study of Vascular Function in Cyclists

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-10

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study with the purpose of measuring vascular function, assessed by evaluating arterial stiffness (pulse wave velocity and augmentation index) and endothelial function (flow mediated dilatation), in elite/amateur symptomatic male cyclists with unilateral Endofibrosis (EF), compared to asymptomatic males cyclists and to a group of age matched healthy males (non-athletes).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predicting Procedural and Long-term Outcomes of Endovascular Revascularization for Lower Extremity Peripheral Artery Chronic Total Occlusions With Computed Tomographic Angiography

NCT03734549

Peripheral Artery Disease

UNKNOWN

Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions

NCT04434586

Superficial Femoral Artery Stenosis Claudication Ischemic Leg

RECRUITING NA

The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting

NCT05455554

Critical Limb Ischemia

UNKNOWN

Acute Local Metabolomic Alterations in Blood and Muscle Tissue in Intermittent Claudication

NCT05111379

Peripheral Arterial Occlusive Disease Fontaine Stage IIa

UNKNOWN

Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg

NCT01893840

Periferal Arterial Occlusive Disease, PAOD

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endofibrosis (EF) of the iliac arteries is a non-atheromatous flow-limiting condition specific to highly trained athletes. Although the pathophysiology is not well understood, haemodynamic injury and mechanical stress are considered to play a key role in developing EF. Recurrent exposure to these factors could trigger an arterial remodelling process that results in an intravascular lesion such as EF that more resembles an "adaptive intimal thickening". Although the natural history of this condition is not known, it is believed to be progressive with increasing numbers of reports of limb threatening ischaemia due to dissection and/or thrombosis of the arterial lumen. Therefore, it is imperative to understand the pathophysiological mechanism behind this condition in order to develop accurate diagnostic and screening criteria/tools for an early identification and characterization of EF. As there are no data in the literature supporting this hypothesis, the investigators have designed this pilot study to evaluate this hypothesis as to whether athletes with EF have evidence of vascular dysfunction in their arteries. There are currently no data on whether athletes who develop EF have underlying arterial disease or abnormalities. It is quite possible that people who develop EF have an underlying systemic endothelial dysfunction and that this may represent a risk factor for the development of the disease. Therefore the investigators will study non-invasively endothelial function (measured as flow mediated dilatation) as well as arterial stiffness (measured as pulse wave velocity and augmentation index) to improve the understanding about the structural and mechanical characteristics of the vascular tree in this cohort of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endothelial Function and Arterial Stiffness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1-Elite Cyclist

10 symptomatic cyclists with unilateral diagnosis of iliac EF,

FLOW MEDIATED DILATION Ankle brachial pressure index (ABPI) PULSE WAVE VELOCITY AND AUGMENTATION INDEX Blood pressure RAMP Test

flow mediated dilation (endothelial function)

Intervention Type OTHER

ABPI

Intervention Type OTHER

Pulse wave velocity and augmentation index

Intervention Type OTHER

blood pressure

Intervention Type OTHER

ramp test

Intervention Type OTHER

2-Amateur Cyclist

10 asymptomatic cyclists with no evidence of EF

FLOW MEDIATED DILATION ABPI PULSE WAVE VELOCITY AND AUGMENTATION Blood pressure RAMP Test

flow mediated dilation (endothelial function)

Intervention Type OTHER

ABPI

Intervention Type OTHER

Pulse wave velocity and augmentation index

Intervention Type OTHER

blood pressure

Intervention Type OTHER

ramp test

Intervention Type OTHER

3-Control

10 age-matched healthy male group

FLOW MEDIATED DILATION ABPI PULSE WAVE VELOCITY AND AUGMENTATION Blood pressure RAMP Test

flow mediated dilation (endothelial function)

Intervention Type OTHER

ABPI

Intervention Type OTHER

Pulse wave velocity and augmentation index

Intervention Type OTHER

blood pressure

Intervention Type OTHER

ramp test

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

flow mediated dilation (endothelial function)

Intervention Type OTHER

ABPI

Intervention Type OTHER

Pulse wave velocity and augmentation index

Intervention Type OTHER

blood pressure

Intervention Type OTHER

ramp test

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

vascular function assessment Duplex ultrasound and ankle brachial pressure index Arterial stiffness 20 minute static cycle ride to exhaustion

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males + 18 years elite or amateur racing cyclists with more than 3 years of training

Exclusion Criteria

* \- Subjects with a previous history of acute coronary syndrome (including myocardial infarction), stroke, transient ischaemic attack, cardiac surgery, other major cardiovascular (CV) surgery, or percutaneous coronary intervention (PCI), carotid surgery or carotid angioplasty, valvular heart, dysrhythmia
* subjects treated with cardiovascular medication for blood pressure, or cholesterol
* subjects with any clinical condition (diabetes, dyslipidaemia, obesity) that in the opinion of the investigator, may have a possible unfavourable effect on patient risk if included in the study, or is likely to interfere with the requirements of the study
* subject with characteristics that may interfere with adherence to the study protocol, such as dementia, substance abuse, history of non-compliance with prescribed medications, or medical appointment
* subject participating in another trial of an investigational drug or device within 30 days prior to screening will be excluded.
* subject that previously underwent surgery for iliac EF
* female subjects
* smokers

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes